Visipaque (GE Healthcare Inc.)


Welcome to the PulseAid listing for the Visipaque drug offered from GE Healthcare Inc.. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: GE Healthcare Inc.
NON-PROPRIETARY NAME: Iodixanol
SUBSTANCE NAME: IODIXANOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
ROUTE: INTRAVASCULAR
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-03-01
END MARKETING DATE: 0000-00-00


Visipaque HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVisipaque from GE Healthcare Inc.
LABELER NAME: GE Healthcare Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 270(mg/mL)
START MARKETING DATE: 2009-03-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0407-2222_53130b10-9dc3-44a0-863d-1b773b126d2a
PRODUCT NDC: 0407-2222
APPLICATION NUMBER: NDA020808

Other IODIXANOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GE Healthcare Inc.Visipaque